Sign in
Taking people in United StatesNo phase

Computer models to guide deep brain stimulation settings for essential tremor

Tests model-guided programming of brain stimulation settings in people with essential tremor.

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
Algorithms for Programming DBS Systems for ET
Status
Recruiting
People taking part
25 people, planned
Started
1 Oct 2019
Expected to end
31 Dec 2031
Type of study
Interventional
Treatments tested
  • Vim-Deep Brain Stimulation
Record updated
27 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with essential tremor who already have a deep brain stimulation (DBS) implant in the Vim area of the brain. It tests computer models that help set the stimulation.

Age
21 years and older
Sex
All sexes
Disease stage
Essential tremor that does not get better with medicines.
Earlier treatment
Must already have a VIM-DBS implant, on one or both sides. Must have had a 7T MRI scan before surgery under Dr. Harel's protocol (#1210M22183) and a CT scan after surgery.

Main reasons for not taking part

  • Past muscle, bone or joint disorders that affect limb movement
  • Another significant disorder of the brain or nerves
  • Past stereotactic brain surgery other than VIM-DBS surgery
  • Pregnancy

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • diagnosis of ET
  • medication-refractory tremor
  • VIM-DBS implant (unilateral or bilateral)
  • 7T MRI pre-operative scan under Dr. Harel's IRB (institutional review board) protocol (#1210M22183)
  • Post-operative CT scan

Who cannot take part

  • prior history of stereotactic neurosurgery (other than VIM-DBS surgery)
  • history of musculoskeletal disorders that affect movement of the limbs
  • other significant neurological disorder
  • pregnancy

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Matthew Johnson, PhDTaking people

About the trial

What the trial wants to find out

Deep brain stimulation (DBS) targeting the Vim thalamus (ventralis intermedius nucleus) is an FDA-approved neuromodulation therapy for treating postural and action tremor in individuals with essential tremor (ET). The success of this treatment, however, is highly dependent on the ability of clinicians to identify therapeutic stimulation settings through a laborious programming process. There is a strong and growing clinical need for new approaches to provide clinicians with more efficient guidance on how to titrate stimulation settings. This study will leverage subject-specific computational models that can predict neural activation of axonal pathways adjacent to the active electrode(s) and implicated in the therapeutic mechanisms of Vim-DBS to in turn guide clinicians with which stimulation settings are likely to be the most therapeutic on tremor.

The group in the trial

  • Deep Brain StimulationTreatment being tested

    Subjects in this study will have been implanted with a DBS lead in the VIM as part of their routine clinical care and have an existing set of brain MRI's.

    Treatment: Vim-Deep Brain Stimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Algorithms for Programming DBS Systems for ET
Plain-language title
Computer models to guide deep brain stimulation settings for essential tremorGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
27 January 2026